Type 1 diabetes Clinical Trials
Recruiting type 1 diabetes studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat type 1 diabetes. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting type 1 diabetes studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting type 1 diabetes trials
ENCRT-103-hPI: Evaluation of an Immune-protected ENCRT-103-hPI Containing Primary Human Islets in Adults With Type 1 Diabetes, With and Without Standard-of-care Portal Vein Islet Infusion.
Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease Modification in Recent-Onset Type 1 Diabetes
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus
Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes
How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver
Targeting GLUT1 to Control Autoimmunity in Type 1 Diabetes
Screening For Social Determinants Of Health In Routine Diabetes Care
Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Therapeutic Outcomes of Using Complementary Hand-based Treatment in Diabetes
Precision T1D Platform - New Therapies for Cardio-Renal Complications
PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study
Feasibility and Effectiveness of an AI-Powered Carbohydrate Counting Educational Platform to Support Parents of Children With Type 1 Diabetes
Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection
Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
Closed Loop Glucose Control in a Simulated ICU Setting
M1no-Study - Early Identification of Infants With High Type 1 Diabetes Risk for Participation in Primary Prevention Trials
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
Universal Type 1 Diabetes Screening in Pediatrics
Think-Find-Solve Activities for Insulin Self-Management in Type 1 Diabetes
Dietary Approaches for the Management of Overweight and Obesity in Type 1 Diabetes
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabetes
CKM For Safe Use of SGLT2i in Type 1 Diabetes
NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes
Effect of a Structured Educational Intervention Through Mobile App on Hemoglobin A1c (HbA1c), Self-Efficacy and Self- Care in Adolescent With Type 1 Diabetes (T1DM)
Feasibility Study of a Continuous Glucose-Ketone Monitoring Device in People With Type 1 Diabetes
Reducing Risk of Diabetic Ketoacidosis in Type 1 Diabetes and Kidney Disease Using Continuous Ketone Monitoring
Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT-2 Inhibitors
Integrating New Skills Into Diabetes Education With CGM
Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management
Finding Immune Nascent Type 1 Diabetes
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus
Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Individualized Exercise Consultation in Type 1 Diabetes
Impact of Dietary Fat and Menstrual Cycle Phases in Type 1 Diabetes
Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies
Effect of 4 Weeks of Oral Probiotic Desulfovibrio Piger Supplementation on Immunological and Metabolic Parameters in Individuals With Longstanding Type 1 Diabetes
"Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds"
Pilot of Food Is Medicine Interventions to Reduce Cardiovascular Disease Risk in Children With Food Insecurity and Diabetes
Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin
Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Simultaneous Measurement and Responsive Treatment - Part 2
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity
Pediatric Insulin Plan Calculator for T1DM Management
Hypoglycemia Fear Affect Autonomic Function, Physical Activity, and Exercise Capacity in Type I Diabetes
Glucose-lowering Drugs as an Adjunct to Insulin Therapy in Chinese Patients With Type 1 Diabetes
Adaptation of REDCHIP Intervention for the Portuguese Context
Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise
Study of IMC-S118AI in Type 1 Diabetes
Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes
Type 1 diabetes clinical trials — common questions
Are type 1 diabetes clinical trials free to join?
Yes. Participating in a type 1 diabetes clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a type 1 diabetes clinical trial?
Each type 1 diabetes study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a type 1 diabetes trial near me?
Use the location controls above. We'll show recruiting type 1 diabetes trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many type 1 diabetes trials are recruiting right now?
We're currently tracking roughly 172 recruiting type 1 diabetes trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.